The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Halozyme has previously licensed the Hypercon technology to other pharmaceutical companies including Janssen, Eli Lilly, and argenx. The company is also known for its ENHANZE drug delivery technology, ...

Halozyme Hypercon has signed an exclusive global collaboration and licence agreement with Oruka Therapeutics for the development of ORKA-001 using Hypercon Technology. Oruka has licensed the Halozyme ...

U.S. company Halozyme Therapeutics, regarded as a competitor to Korea's bio corporations Alteogen, will acquire Elektrofi, which has subcutaneous injection drug delivery technology, for up to $900 ...

Halozyme Therapeutics, Inc. (NASDAQ:HALO) is one of the most undervalued biotech stocks to buy right now. Halozyme Therapeutics, Inc. (NASDAQ:HALO) announced on April 7 that its wholly-owned ...

Earlier this week, Halozyme Therapeutics’ subsidiary Halozyme Hypercon announced a global exclusive collaboration and license agreement granting Vertex Pharmaceuticals access to its Hypercon ...